David Turkaly
Stock Analyst at Citizens
(2.22)
# 2,837
Out of 5,055 analysts
143
Total ratings
41.22%
Success rate
-3.34%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TELA TELA Bio | Maintains: Market Outperform | $7 → $5 | $1.00 | +400.35% | 7 | Nov 14, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $3.90 | +105.13% | 6 | Nov 12, 2025 | |
| AXGN Axogen | Maintains: Market Outperform | $26 → $34 | $23.54 | +44.47% | 8 | Oct 30, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $16.74 | +49.34% | 12 | Oct 10, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $53.01 | +37.71% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $14.96 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $84.45 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $73.49 | +36.07% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $258.41 | +8.35% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $11.77 | +112.40% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $29.99 | +83.39% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $140 → $125 | $89.91 | +39.03% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $537.55 | -6.99% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $362.22 | - | 3 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $107.00 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $17.42 | +83.70% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $8.57 | +86.70% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $1.99 | +50.75% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.46 | -40.90% | 1 | Oct 6, 2017 |
TELA Bio
Nov 14, 2025
Maintains: Market Outperform
Price Target: $7 → $5
Current: $1.00
Upside: +400.35%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $3.90
Upside: +105.13%
Axogen
Oct 30, 2025
Maintains: Market Outperform
Price Target: $26 → $34
Current: $23.54
Upside: +44.47%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $16.74
Upside: +49.34%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $53.01
Upside: +37.71%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $14.96
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $84.45
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $73.49
Upside: +36.07%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $258.41
Upside: +8.35%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $11.77
Upside: +112.40%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $29.99
Upside: +83.39%
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $89.91
Upside: +39.03%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $537.55
Upside: -6.99%
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $362.22
Upside: -
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $107.00
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $17.42
Upside: +83.70%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $8.57
Upside: +86.70%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $1.99
Upside: +50.75%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.46
Upside: -40.90%